|
|
Analysis of the expression and clinical significance of LncRNA LINC00319 expression in lung adenoarinoma utilizing TCGA datasets |
CHEN Shaoting CAO Pengju YANG Yang CHEN Falin |
Clinical Lab, Fujian Provincial Hospital, Fujian Province, Fuzhou 350001, China |
|
|
Abstract Objective To investigate the expression and clinical significance of long non-coding RNA (lncRNA) LINC00319 in lung adenocarcinoma and its adjacent tissues. Methods The RNAseq data of 516 cases of lung adenocarcinoma tissues (tumor group) and 59 cases of paracancer tissues (para-cancer control group) and the corresponding clinical data of lung adenocarcinoma patients were downloaded from the cancer genome atlas (TCGA) database, and the expression of LINC00319 gene in the data set was analyzed and processed. The correlation between its expression and the clinicopathological features of lung adenocarcinoma and its effect on prognosis were analyzed and compared. Independent risk factors for prognosis of patients with lung adenocarcinoma were assessed by COX risk ratio model. Gene set enrichment analysis (GSEA) was used to predict the functional enrichment of LINC00319 molecular pathways. Results The expression level of LINC00319 in tumor group was significantly higher than that in the para-carcinoma control group (P < 0.05). The expression level had no correlation with gender, age and N-staging (P > 0.05), and significantly correlated with smoking, T-staging, M-staging and Stage grading (P < 0.05). Survival analysis showed that high LINC00319 expression predicted worse prognosis in lung adenocarcinoma patients (P < 0.05). The results of multiariable COX risk scale model showed that, high expression level, stage Ⅲ+Ⅳ and T3+T4 were independent risk factors for poor prognosis of patients with lung adenocarcinoma (P < 0.05). In GSEA analysis, it was found that LINC00319 mainly enriched in cell adhesion, cytokine interaction, vascular endothelial growth factor signaling pathway, apoptosis and other pathways. Conclusion LINC00319 may promote the occurrence and development of lung adenocarcinoma through various ways, thereby affecting the prognosis and survival of lung adenocarcinoma patients. Therefore, LINC00319 can be used as a prognostic marker or potential therapeutic target for lung adenocarcinoma patients.
|
|
|
|
|
[1] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012 [J]. CA Cancer J Clin,2015,65(2):87-108.
[2] Siegel RL,Miller KD,Jemal A. Cancer statistics,2016 [J]. CA Cancer J Clin,2016,66(1):7-30.
[3] Chen WQ,Zheng RS,Baade PD,et al. Cancer statistics in China 2015 [J]. CA Cancer J Clin,2016,66(2):115-132.
[4] Ponting CP,Oliver PL,Reik W. Evolution and Functions of Long Noncoding RNAs [J]. Cell,2009,136(4):629-641.
[5] Mercer TR,Dinger ME,Mattick JS. Long non-coding RNAs:insights into functions [J]. Nat Rev Genet,2009,10(3):155-159.
[6] Fatica A,Bozzoni I. Long non-coding RNAs:new players in cell differentiation and development [J]. Nat Rev Genet,2013,15(1):7-21.
[7] Jiang T,Guo J,Hu Z,et al. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis [J]. Med Sci Monit,2018,20(24):4213-4239.
[8] Seiler J. The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance [J]. Nucleic Acids Res,2017,45(9):5458-5469.
[9] Wang C,Gu Y,Zhang E,et al. A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma [J]. Oncogene,2019,38(10):1611-1624.
[10] He J,Wu K,Guo CL. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration NSCLC [J]. Cell Mol Life Sci,2018,75(24):4667-4681.
[11] Zhao W,Zhang LN,Wang XL,et al. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1 [J]. FASEB J,2019, 33(1):1151-1166.
[12] Wang Y,Zhou J,Xu YJ,et al. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway [J]. Cell Physiol,2018,233(4):3397-3406.
[13] Hu L,Chen SH,Lv QL. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility,Platinum-Based Chemotherapy Response,and Toxicity [J]. Environ Res Public Health,2016,13(6):545-557.
[14] 李雪萍,梁鑫,刘政,等.LncRNA LOC90024对肺癌细胞生长、迁移和侵袭的影响[J].西安交通大学学报:医学版,2019,40(1):43-48.
[15] Lu KH,LI W,Liu XH,et al. Long non-coding RNA MEG3 inhibits NSCLC cells prolifcration and induces apoptosis by af fecting p53 expression [J]. BMC Cancer,2013,13(1):461-472.
[16] Zhou B,Yuan W,Li XL,et al. Intergenic Noncoding RNA 319 (linc00319) Promotes Cell Proliferation and Invasion in Lung Cancer Cells by Directly Downregulating the Tumor Suppressor MiR-32 [J]. Oncol Res,2017.
[17] Du W,Feng Z,Sun Q. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway [J]. Bioch em Biophys Res Commun,2018,507(14):198-202.
[18] Song P,Yin SC. Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis [J]. Gene,2019,5(680):51-58.
[19] Li F,Liao J,Duan X. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma [J]. Cell Biochem,2018,119(12):10 393-10 405.
[20] Zhang ZW,Chen JJ,Xia SH,et al. Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2 [J]. Gene,2018,15(650):60-67. |
|
|
|